TY - JOUR
T1 - Adrenocortical carcinoma characterized by gynecomastia
T2 - A case report
AU - Takeuchi, Takako
AU - Yoto, Yuko
AU - Ishii, Akira
AU - Tsugawa, Takeshi
AU - Yamamoto, Masaki
AU - Hori, Tsukasa
AU - Kamasaki, Hotaka
AU - Nogami, Kazutaka
AU - Oda, Takanori
AU - Nui, Akihiro
AU - Kimura, Sachiko
AU - Yamagishi, Takuya
AU - Homma, Keiko
AU - Hasegawa, Tomonobu
AU - Fukami, Maki
AU - Watanabe, Yoko
AU - Sasamoto, Hidehiko
AU - Tsutsumi, Hiroyuki
N1 - Publisher Copyright:
© 2018 by The Japanese Society for Pediatric Endocrinology.
PY - 2018
Y1 - 2018
N2 - We present a 4-yr-old boy with adrenocortical carcinoma (ACC), diagnosed due to the appearance of gynecomastia as the presenting symptom. Six months prior to admission, an acute growth spurt along with the development of bilateral breast swelling was observed. He did not present any features of virilization, including enlargement of the testes, increase in testis volume, and penis size. Laboratory investigations showed gonadotropin-independent hypergonadism, with low LH/ FSH levels and elevated estradiol/testosterone levels. Abdominal computed tomography revealed a large heterogeneous mass adjacent to the right kidney and below the liver. Pathological investigations of the biopsy specimen demonstrated that the tumor was an ACC. Pre- and post-operative combination chemotherapy with mitotane was administered and surgical resection was carried out. Post-surgery, the elevated estradiol/testosterone concentrations reverted to within the reference range. Urinary steroid profile and tissue concentration analysis of estradiol and testosterone indicated the presence of estrogen in the ACC tissue. An investigation for TP53 gene aberrations revealed the presence of a germline point mutation in exon 4 (c.215C>G (p.Pro72Arg)). In ACC, the most common symptom is virilization, and feminization, characterized by gynecomastia, is very rare. However, a diagnostic possibility of ACC should be considered when we encounter patients who have developed gynecomastia without the influence of causative factors such as obesity or puberty, and do not present with the typical signs of virilization.
AB - We present a 4-yr-old boy with adrenocortical carcinoma (ACC), diagnosed due to the appearance of gynecomastia as the presenting symptom. Six months prior to admission, an acute growth spurt along with the development of bilateral breast swelling was observed. He did not present any features of virilization, including enlargement of the testes, increase in testis volume, and penis size. Laboratory investigations showed gonadotropin-independent hypergonadism, with low LH/ FSH levels and elevated estradiol/testosterone levels. Abdominal computed tomography revealed a large heterogeneous mass adjacent to the right kidney and below the liver. Pathological investigations of the biopsy specimen demonstrated that the tumor was an ACC. Pre- and post-operative combination chemotherapy with mitotane was administered and surgical resection was carried out. Post-surgery, the elevated estradiol/testosterone concentrations reverted to within the reference range. Urinary steroid profile and tissue concentration analysis of estradiol and testosterone indicated the presence of estrogen in the ACC tissue. An investigation for TP53 gene aberrations revealed the presence of a germline point mutation in exon 4 (c.215C>G (p.Pro72Arg)). In ACC, the most common symptom is virilization, and feminization, characterized by gynecomastia, is very rare. However, a diagnostic possibility of ACC should be considered when we encounter patients who have developed gynecomastia without the influence of causative factors such as obesity or puberty, and do not present with the typical signs of virilization.
KW - Adrenocortical carcinoma
KW - Gynecomastia
KW - TP53
UR - http://www.scopus.com/inward/record.url?scp=85042049790&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042049790&partnerID=8YFLogxK
U2 - 10.1297/cpe.27.9
DO - 10.1297/cpe.27.9
M3 - Article
AN - SCOPUS:85042049790
SN - 0918-5739
VL - 27
SP - 9
EP - 18
JO - clinical pediatric endocrinology
JF - clinical pediatric endocrinology
IS - 1
ER -